Latest database descriptions

Short term:
- Describe patient's characteristics
- Analyze factors associated to a treatment of hepatitis C: beginning of the treatment, continuation or stop of the treatment.
- Validate the field performance of not-invasive markers of hepatic fibrosis.

Mid-term:
- Realize an observational study of the evolution of hepatitis during an anti-VHC treatment, in an antiviral situation
- Study the clinical and biological tolerance to the different treatments.
- Study the impact of the observance of the treatment anti HIV and the life quality of patients.

Long term:
Study the natural history of chronic hepatitis, in particular at the stage of cirrhosis.
- Analyze the factors associated to the evolution to fibrosis, to a decompensated hepatic disease or an hepatocellular carcinoma.
- Evaluate the effects of antiretroviral agents on the evolution of not-treated hepatitis
- Study the potential interactions between different virus of hepatitis

Describe the prevalence of the facial lipoatrophy in patients infected by HIV virus and receiving antiretroviral drugs. Describe the prevalence of lipoatrophies and lipodystrophic mixed syndromes.
Evaluate the score of quality of life, using the patients multi-dimensional auto-questionnaire and specific ABCD "Assessment of Body Change and Distress".

To describe the characteristics of people pharmacologically treated for diabetes, their health with regards to diabetes, the quality of care received, treatment plan and self-management education; their quality of life, experiences and requirements in terms of education and information, as well as the cost of diabetes.

EPICEA is an experience feedback database.
The aim is to share knowledge obtained from analysing work-related accidents. The accounts provided describe the causes and course of a specific type of accident without seeking to establish liability.
The EPICEA database available online is an extract of the full, non-public version.